IL17A and metabolic dysfunction-associated steatohepatitis: Consistent with suppression of the Th17/IL-17 axis in NASH models, FGF21 reduces the expression of IL-17 and the expansion of Th17 cells in a mouse model of rheumatoid arthritis (188).